首页> 外文OA文献 >TCT-45 Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-World Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study

【2h】

TCT-45 Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-World Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study

机译：TCT-45 XIENCEV®依维莫司洗脱冠状动脉支架系统在现实世界人群中的长期安全性和有效性：XIENCEV®USA研究的三年临床结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hermiller James; Krucoff Mitchell; zhao weiying; Gruberg Luis; Lombardi William; Rutledge David; Wang Jin; Mao Vivian;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. A new era of prospective real-world safety evaluation: Primary report of XIENCE v USA (XIENCE v Everolimus Eluting Coronary Stent System Condition-of-Approval Post-Market Study) [J] . KrucoffM.W., RutledgeD.R., GrubergL., JACC. Cardiovascular interventions . 2011,第12期

机译：前瞻性现实世界安全评估的新时代：XIENCE诉美国的主要报告（XIENCE诉Everolimus洗脱冠状动脉支架系统的批准后市场条件研究）
2. Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V? USA study [J] . Journal of interventional cardiology . 2012,第6期

机译：在一项大型的前瞻性批准研究中，接受依维莫司洗脱冠状动脉支架系统的现实世界患者的临床事件发生率持续较低：XIENCE V？2年临床结果如何？美国学习
3. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents: Pooled analysis from the SPIRIT (Clinical evaluation of the XIENCE v everolimus eluting coronary stent system) and COMPARE (second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) randomized trials [J] . ClaessenB.E., SmitsP.C., KereiakesD.J., JACC. Cardiovascular interventions . 2011,第11期

机译：依维莫司和紫杉醇洗脱支架经皮冠状动脉介入治疗后病变长度和血管大小对临床结果的影响：来自SPIRIT（XIENCE v依维莫司洗脱冠状动脉支架系统的临床评估）和COMPARE（第二代依维莫司洗脱）的合并分析和紫杉醇洗脱支架在现实生活中的应用）随机试验
4. Early and long term clinical outcomes from the treatment of proximal LAD stenoses with drug-eluting stents, in real-world clinical practice. [C] . Graidis C., Dimitriadis D., Ntatsios A., International Congress on Coronary Artery Disease . 2009

机译：早期和长期的临床结果从近端小伙子的近端狭窄与毒品洗脱支架，在现实世界临床实践中。
5. A clinical evaluation of the XIENCE V everolimus eluting stent in the treatment of patients with coronary artery disease: Result from Thailand Registry – XIENCE V performance evaluation (THRIVE study) [O] . Songsak Kiatchoosakun, Pavit Pienvichit, Srun Kuanprasert, 2017

机译：XIENCE V依维莫司洗脱支架在冠心病患者治疗中的临床评估：泰国注册处的结果– XIENCE V性能评估（THRIVE研究）
6. A New Era of Prospective Real-World Safety Evaluation Primary Report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System Condition-of-Approval Post-Market Study) [O] . Krucoff Mitchell W., Rutledge David R., Gruberg Luis, 2011

机译：XIENCE V USA的前瞻性现实世界安全评估新纪元报告（XIENCE V Everolimus洗脱冠状动脉支架系统的批准后市场条件研究）

TCT-45 Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-World Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study

著录项

引文网络

相似文献

相关主题

期刊订阅